Mineralys Therapeutics Analyst Ratings
BenzingaApr 2 19:10
Goldman Sachs Initiates Coverage On Mineralys Therapeutics With Buy Rating, Announces Price Target of $30
BenzingaApr 2 19:10
Analysts Offer Insights on Healthcare Companies: Resmed (RMD), Mineralys Therapeutics, Inc. (MLYS) and Addus Homecare (ADUS)
TipRanksMar 22 17:20
Buy Rating Affirmed for Mineralys Therapeutics Amid Positive Clinical and Strategic Developments
TipRanksMar 22 17:18
Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX) and Mineralys Therapeutics, Inc. (MLYS)
TipRanksSep 11, 2023 17:31
Credit Suisse: Maintaining the Mineralys Therapeutics (MLYS.US) rating, adjusted from superior to market ratings, the target price was adjusted from $38.00 to $37.00.
Zhitong FinanceAug 8, 2023 20:21
Credit Suisse Maintains Outperform on Mineralys Therapeutics, Lowers Price Target to $37
BenzingaAug 8, 2023 20:16
Mineralys Therapeutics Analyst Ratings
BenzingaAug 8, 2023 20:15
Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Eli Lilly & Co (LLY)
TipRanksAug 8, 2023 09:20
Mineralys Therapeutics, Inc. (MLYS) Gets a Buy From Credit Suisse
TipRanksMay 16, 2023 20:35
Credit Suisse: Reiterating the Mineralys Therapeutics (MLS.US) rating, adjusted from superior to the big market rating to superior to the big market rating. The target price is 38.00 US dollars.
Zhitong FinanceMay 16, 2023 19:21
Analysts Conflicted on These Healthcare Names: Molina Healthcare (MOH), Cara Therapeutics (CARA) and Mineralys Therapeutics, Inc. (MLYS)
TipRanksMay 16, 2023 17:31
Credit Suisse Adjusts Mineralys Therapeutics' Price Target to $38 From $40, Keeps Outperform Rating
MT NewswiresMar 16, 2023 22:36
Credit Suisse Maintains Outperform on Mineralys Therapeutics, Lowers Price Target to $38
BenzingaMar 16, 2023 19:47
Analysts Offer Insights on Healthcare Companies: Aravive (ARAV), Prelude Therapeutics (PRLD) and Mineralys Therapeutics, Inc. (MLYS)
TipRanksMar 16, 2023 17:57
Credit Suisse Starts Mineralys Therapeutics at Outperform With $40 Price Target, Says Potential Near-Term Partnership Could Boost Stock Value
MT NewswiresMar 7, 2023 21:25
Stifel Initiates Coverage On Mineralys Therapeutics With Buy Rating, Announces Price Target of $45
BenzingaMar 7, 2023 18:25
Analysts Are Bullish on Top Healthcare Stocks: Unity Biotechnology (UBX), Mineralys Therapeutics, Inc. (MLYS)
TipRanksMar 7, 2023 17:35
No Data
No Data